Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response

Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response

Abstract Immunotherapies employing PD‐1/PD‐L1 immune checkpoint inhibitors (ICIs) are vital for primary liver cancer (PLC), but response rates remain unsatisfying. Accurate differentiation of responders from non‐responders to immunotherapy is imperative. Here, single‐cell‐scaled mass cytometry analy...

Full description

Bibliographic Details
Main Authors: Jun Xue, Shuai Yang, Si‐Si Zhang, Jun Fan, Zi‐Long Wu, Cheng‐Jun Sui, Yong‐Qiang Yang, Jin‐Feng Zhang, Pian Liu, De‐Jun Zhang, Xin‐Yao Qiu, Tao Zhang, Lei Chen, Gang Wu, Hong‐Yang Wang, Jing Tang
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Advanced Science
Subjects:
efficacy prediction model
immune‐checkpoint inhibition‐based therapy
peripheral immune landscapes
primary liver cancer
Online Access:https://doi.org/10.1002/advs.202309631

Internet

https://doi.org/10.1002/advs.202309631

Similar Items